Charlottesville, VA — October 29, 2004 —Diffusion Pharmaceuticals LLC, a pharmaceutical company which discovers and develops novel small-molecule therapeutics for the treatment of oxygen deficiency in tissues, today announced its selection as the winner of the Virginia’s Technology Capital Access Forum’s (VTCAF) business plan competition, receiving the $10,000 cash prize sponsored by Third Security, LLC. [...]

CHARLOTTESVILLE, VA — Tuesday, September 7, 2004 — Diffusion Pharmaceuticals, an early-stage pharmaceutical company which discovers and develops novel small-molecule therapeutics, today announced it has been awarded a $1 million appropriation in the FY 2005 Defense Budget, which President Bush signed last month. These funds are allocated for studies to advance its lead compound, trans [...]